Accessibility Menu
 
Surmodics logo

Surmodics

(NASDAQ) SRDX

Current PriceN/A
Market CapN/A
Since IPO (1998)+958%
5 Year+15%
1 Year+10%
1 Month+54%

Surmodics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$120.80M

Net Income (TTM)

$17.63M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

SRDX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surmodics

Industry

Healthcare Equipment and Supplies

Employees

389

CEO

Gary R. Maharaj, MBA

Headquarters

Eden Prairie, MN 55344-3523, US

SRDX Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

-10%

Net Income Margin

-15%

Return on Equity

-16%

Return on Capital

-8%

Return on Assets

-10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$93.05M

Operating Income

$5.64M

EBITDA

$4.73M

Operating Cash Flow

$248.00K

Capital Expenditure

$3.49M

Free Cash Flow

$3.24M

Cash & ST Invst.

$40.11M

Total Debt

$33.24M

Surmodics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$29.57M

-2.6%

Gross Profit

$20.99M

-0.2%

Gross Margin

70.99%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

389

N/A

Net Income

$5.32M

+29.6%

EBITDA

$5.24M

-86.8%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$146.00K

-96.9%

Accounts Receivable

$25.02M

+4.0%

Inventory

$15.76M

+2.3%

Long Term Debt

$31.56M

-2.7%

Short Term Debt

$1.02M

-49.9%

Return on Assets

-10.38%

N/A

Return on Invested Capital

-8.21%

N/A

Free Cash Flow

$904.00K

+130.2%

Operating Cash Flow

$1.41M

+169.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KIDSOrthoPediatrics Corp.
$16.47-0.30%
TMCITreace Medical Concepts, Inc.
$1.26+1.61%
CBLLCeriBell, Inc.
$19.00+2.70%
SMLRSemler Scientific, Inc.
$20.33-4.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
UGROUrban-gro
$6.15+1.82%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.57+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.85+0.07%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$77.48-0.03%

Questions About SRDX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.